 I just I want to make sure I answered Mark's second question very quickly. You know, there's an injectable drug now that you can give twice a year, Linacapavir, which is just extraordinary. In a recent trial, it had essentially 100 percent efficacy in preventing acquisition of infection in cisgender women.